- Amersham Becomes "GE Healthcare"
- General Electric Company completed
the acquisition Amersham Healthcare this month and will now be known
as GE Healthcare. Sir William Castell, formerly Chief
Executive of Amersham, assumes the role of President and CEO of GE
Healthcare.
For
more information....
-
- APhA Annual Meeting
Handouts
- If you missed the fun and the great
educational sessions at the APhA meeting in Seattle, you will still
be able to get the handouts for many of the sessions from the
APhA meeting website beginning May 3. (Look for pictures of the
meeting in next month's newsletter.)
-
- Action Item: Contact Your
Senator
- In order to produce the medical
isotopes necessary for 90 percent of nuclear medicine procedures,
the manufacturers of medical isotopes must have access to small
quantities of highly enriched uranium (HEU). That supply is in
jeopardy of being disrupted, please ask your senator to support the
medical isotope provision included within energy legislation, S.
2095, the “Energy Policy Act of 2003. For more information and
sample letters
click here.
Boston
Life Sciences Gets OK for Altropane Phase III Trial
Pharmaceutical firm Boston Life Sciences has reached an agreement with
the Food and Drug Administration for the phase III clinical trial of
its radioimaging agent Altropane.
For more information....
- Virtual Mentors
Needed for Nuclear Pharmacy
- APhA recently launched
a Career Center on pharmacist.com that provides several
career-related services to pharmacy students, new practitioners,
and pharmacists looking for a mid-career change. The Virtual
Mentor program connects interested individuals with pharmacists
currently working in a specific area - like nuclear. The
individuals can read about nuclear pharmacists and email questions
or ask for advice.
-
Comments or Suggestions?
Let us know your thoughts about the newsletter.
| May 7 |
Extended deadline for Section
officer applications. See
www.aphanet.org
|
| May
14-16 |
"Charities
& Maladies" Continuing Education Weekend, Ft. Myers, FL |
|
May 14-16 |
Central Chapter SNM Meeting, Chicago, IL |
|
May 21-22 |
2nd Annual 2004 PET/CT Imaging Symposium, Las Vegas,
Nevada |
|
June 19-23 |
SNM 51st Annual Meeting, Philadelphia, PA |
|
Sept. 4-9 |
FIP Annual Meeting,
New Orleans, LA |
|
Sept. 4-8 |
European
Nuclear Medicine Meeting, Helsinki, Finland |
|
Sept. 9-12 |
Third Annual Meeting of the Society for Molecular Imaging
St. Louis, Missouri |
|
Sept. 10-12 |
Southeastern Chapter Meeting
Clearwater Beach, Florida |
If this
email does not view graphics properly go to
http://www.nuclearonline.org/newsletter/April04.htm |
|
|
- Just below gamma
& x-rays on the electromagnetic spectrum you will
find ultraviolet radiation. With summer
approaching, it is time to pay attention to the
hazards of solar radiation. UV radiation is
associated with skin cancer, suppression of the
immune system, cataracts, and premature aging of
the skin. There are three types of UV rays:
-
- UVA - Not
absorbed by ozone layer, causes damage to
connective tissue and increases risk of skin
cancer.
- UVB -
Mostly absorbed by ozone layer, does not
penetrate skin as deep as UVA, causes reddening
of the skin.
- UVC -
Extremely hazardous to skin, but is completely
absorbed by ozone and oxygen.
-
- To check the
daily UV index in your area go to the
EPA or
Accuweather website. Remember
the ALARA concept!
|
|
| |
A 64 year old woman with
Non-Hodgkin's lymphoma treated with CHOP (cyclo-phosphamide,
doxorubicin, vincristine, & prednisone) and G-CSF.
Continued....
Brought to you by
- © 2004 Nuclear Education Online
- 4301 W. Markham #522
- Little Rock, AR 72205
- 501-686-6398
- For more information, contact
Nicki Hilliard
To subscribe to this mailing list
click here.
|
